Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-26-057366

Chief Financial Officer acquired 9,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Steinhart Richard I · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-01 Exercise or conversion : show line 1 in the form +9,000 15,645 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-01 Exercise or conversion : show line 2 in the form Restricted Stock Units −9,000 0 D
Loading xslF345X06/tm2613630-3_4seq1.xml…